COVID-19 Severe Respiratory Failure
1 clinical trials · Condition
◉ Watch COVID-19 Severe Respiratory Failure
| Record | Firm | Date |
|---|---|---|
| Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19 (NCT05279391) | Democritus University of Thrace | 2020-10-25 |
Track COVID-19 Severe Respiratory Failure automatically
Every clearance here is in the API, with alerts when new ones post.